January 9, 2025 - 17:10

In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
February 11, 2026 - 05:36
Five ways quantum technology could shape everyday lifeThe recent unveiling of advanced quantum supercomputers by industry leaders underscores a pivotal shift. Quantum technology is rapidly transitioning from theoretical research to tangible...
February 10, 2026 - 18:44
Police report slower drivers as speed camera technology expands throughout stateThe statewide expansion of automated speed enforcement technology is producing a noticeable shift in driver behavior, according to recent police reports. Officers indicate that the mere presence of...
February 10, 2026 - 12:40
Navigating Home Health’s Technology ImperativeThe home health sector stands at a pivotal crossroads, grappling with the dual challenge of maintaining financial viability while pioneering new models of care. In this complex landscape,...
February 9, 2026 - 21:12
Technology update, How to cut back on screen time, Tech, textiles and sportsThis week`s technology discussion delves into the complex relationship we have with our devices, offering insights on security, wellness, and innovation. Cybersecurity expert Beth D’Angelo...